-+ 0.00%
-+ 0.00%
-+ 0.00%

CRESCENT BIOPHARMA ANNOUNCES FIRST PATIENT DOSED IN ASCEND PHASE 1/2 CLINICAL TRIAL OF CR-001 FOR THE TREATMENT OF ADVANCED SOLID TUMORS

Reuters·02/18/2026 12:30:00

Please log in to view news